oPool+ (IMAGE)
Caption
The oPool+ display platform combines technologies to make and test large numbers of antibodies at once. Illinois researchers analyzed how antibodies bind to the influenza protein hemagglutinin.
Credit
Image by Owen Ouyang
Usage Restrictions
Credit Owen Ouyang
License
Original content